KIM, Yeon-Joo et al. A phase II study of hypofractionated proton therapy for prostate cancer. Acta Oncologica, [S. l.], v. 52, n. 3, p. 477–485, 2013. DOI: 10.3109/0284186X.2013.764011. Disponível em: https://medicaljournalssweden.se/actaoncologica/article/view/27716. Acesso em: 21 feb. 2025.